Phase
Condition
Obesity
Diabetes Prevention
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Informed consent obtained before any trial-related activities. Trial-relatedactivities are any procedures that are carried out as part of the trial, includingactivities to determine suitability for the trial
BMI above or equal to 30 kg/m^2
Male or female, age 18 years or older at the time of signing informed consent
Exclusion
Exclusion Criteria:
HbA1c (glycosylated haemoglobin) above or equal to 6.5% (at screening visit), ordiagnosis of type 1 or type 2 diabetes mellitus
Recent history of cardiovascular disease (myocardial infarction or stroke within thepast 6 months), severe congestive heart failure (NYHA class III, IV), or second degreeor greater heart block
Personal or family history of Medullary Thyroid Carcinoma (MTC), or Multiple EndocrineNeoplasia type 2 (MEN2)
Female who is pregnant, breast-feeding or intends to become pregnant or is ofchild-bearing potential and not using an adequate contraceptive method (adequatecontraceptive measure as required by local regulation or practice)
Use in past 90 days of medications known to induce significant weight loss (e.g.,prescription weight loss medications) or weight gain (e.g., chronic use of oralsteroids, second generation antipsychotics)
History of pancreatitis (acute or chronic)
History of major depressive disorder within the past 2 years
Any lifetime history of a suicide attempt
Inadequately treated blood pressure defined as Grade 3 hypertension or higher (Systolic above or equal to 180 mmHg or diastolic above or equal to 110 mmHg)
History of malignancy (except for non-melanoma skin cancer) within the past 5 years
Study Design
Connect with a study center
Novo Nordisk Investigational Site
Anaheim, California 92801
United StatesSite Not Available
Novo Nordisk Investigational Site
Jacksonville, Florida 32205
United StatesSite Not Available
Novo Nordisk Investigational Site
Plantation, Florida 33324
United StatesSite Not Available
Novo Nordisk Investigational Site
Chicago, Illinois 60607
United StatesSite Not Available
Novo Nordisk Investigational Site
North Dartmouth, Massachusetts 02747
United StatesSite Not Available
Novo Nordisk Investigational Site
Butte, Montana 59701
United StatesSite Not Available
Novo Nordisk Investigational Site
Greensboro, North Carolina 27408
United StatesSite Not Available
Novo Nordisk Investigational Site
Salisbury, North Carolina 28144
United StatesSite Not Available
Novo Nordisk Investigational Site
Wilmington, North Carolina 28401
United StatesSite Not Available
Novo Nordisk Investigational Site
Wadsworth, Ohio 44281
United StatesSite Not Available
Novo Nordisk Investigational Site
Philadelphia, Pennsylvania 19104-3317
United StatesSite Not Available
Novo Nordisk Investigational Site
Charleston, South Carolina 29425
United StatesSite Not Available
Novo Nordisk Investigational Site
Greer, South Carolina 29651
United StatesSite Not Available
Novo Nordisk Investigational Site
Bristol, Tennessee 37620
United StatesSite Not Available
Novo Nordisk Investigational Site
Dallas, Texas 75251
United StatesSite Not Available
Novo Nordisk Investigational Site
Arlington, Virginia 22206
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.